Target Name: RNF103
NCBI ID: G7844
Review Report on RNF103 Target / Biomarker Content of Review Report on RNF103 Target / Biomarker
RNF103
Other Name(s): KF1 | ZFP-103 | zinc finger protein 103 homolog | ring finger protein 103 | RNF103 variant 1 | RING-type E3 ubiquitin transferase RNF103 | Ring finger protein 103, transcript variant 1 | KF-1 | ZFP103 | RING finger protein 103 | HKF-1 | zinc finger protein expressed in cerebellum | hKF-1 | E3 ubiquitin-protein ligase RNF103 (isoform 1) | Zinc finger protein 103 homolog | Zfp-103 | E3 ubiquitin-protein ligase RNF103 | RN103_HUMAN

KF1: A RNA-Nucleic Acid Factor Regulating Gene Expression and Cell Processes

RNA-Nucleic Acid (RNA) factors are a class of proteins that play a crucial role in various cellular processes. One of the key RNA factors is the RNA Nucleic Acid (RNA) factor Kappa B (KF1). KF1 is a protein that is expressed in various cell types and is involved in the regulation of gene expression.

KF1 is a key regulator of the nuclear factor of activating transcription (NFAT) complex, which is responsible for promoting the expression of genes involved in cell signaling pathways. The NFAT complex is a protein complex that consists of several transcription factors, including KF1. KF1 plays a vital role in the regulation of gene expression by binding to specific DNA sequences and activating or repressing the activity of the transcription factors.

KF1 has been shown to play a key role in the regulation of various cellular processes, including cell growth, apoptosis, and transcriptional regulation. KF1 has been shown to promote the growth of cancer cells and contribute to their survival. It has also been shown to play a key role in the regulation of cell apoptosis, which is the process by which cells undergo programmed cell death.

KF1 has been shown to promote the expression of genes involved in cell signaling pathways, including cell proliferation and differentiation. It has been shown to inhibit the activity of transcription factors that promote the expression of genes involved in cell death, such as p53. This suggests that KF1 may have a negative impact on the survival of cancer cells.

KF1 has also been shown to play a key role in the regulation of inflammation. It has been shown to promote the expression of genes involved in inflammation and to inhibit the expression of genes involved in anti-inflammatory responses. This suggests that KF1 may contribute to the regulation of the balance between pro-inflammatory and anti-inflammatory responses in the body.

KF1 has been shown to play a key role in the regulation of stem cell maintenance. It has been shown to promote the self-renewal and maintenance of stem cells, which are a vital source of cells involved in various therapeutic applications. This suggests that KF1 may have a role in the development and maintenance of stem cells.

In conclusion, KF1 is a protein that plays a crucial role in various cellular processes. Its regulation of gene expression, cell growth, apoptosis, and inflammation suggests that it may be a valuable drug target or biomarker for the development of new therapeutic applications. Further research is needed to fully understand the role of KF1 in cellular processes and to develop new therapeutic approaches.

Protein Name: Ring Finger Protein 103

Functions: Acts as an E2-dependent E3 ubiquitin-protein ligase, probably involved in the ER-associated protein degradation pathway

The "RNF103 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNF103 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

RNF103-CHMP3 | RNF11 | RNF111 | RNF112 | RNF113A | RNF113B | RNF114 | RNF115 | RNF121 | RNF122 | RNF123 | RNF125 | RNF126 | RNF126P1 | RNF128 | RNF13 | RNF130 | RNF133 | RNF135 | RNF138 | RNF138P1 | RNF139 | RNF139-DT | RNF14 | RNF141 | RNF144A | RNF144B | RNF145 | RNF146 | RNF148 | RNF149 | RNF150 | RNF151 | RNF152 | RNF157 | RNF157-AS1 | RNF165 | RNF166 | RNF167 | RNF168 | RNF169 | RNF17 | RNF170 | RNF175 | RNF180 | RNF181 | RNF182 | RNF183 | RNF185 | RNF186 | RNF187 | RNF19A | RNF19B | RNF2 | RNF20 | RNF207 | RNF208 | RNF212 | RNF212B | RNF213 | RNF213-AS1 | RNF214 | RNF215 | RNF216 | RNF216-IT1 | RNF216P1 | RNF217 | RNF217-AS1 | RNF220 | RNF222 | RNF224 | RNF225 | RNF227 | RNF24 | RNF25 | RNF26 | RNF31 | RNF32 | RNF32-DT | RNF34 | RNF38 | RNF39 | RNF4 | RNF40 | RNF41 | RNF43 | RNF44 | RNF5 | RNF5P1 | RNF6 | RNF7 | RNF7P1 | RNF8 | RNFT1 | RNFT2 | RNGTT | RNH1 | RNLS | RNMT | RNPC3